PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
NCT03172481
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
156
Enrollment
INDUSTRY
Sponsor class
Conditions
ADHD
Interventions
DRUG:
PRC-063 oral capsules
DRUG:
Placebo oral capsules
Sponsor
Purdue Pharma, Canada